Atlas Trials

BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab

Clinical trial NCT00625898 · TERMINATED

Trial details

NCT number
NCT00625898
Sponsor
NSABP Foundation Inc
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2008-04-01
Primary completion
2013-06-01
Enrollment
3509

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.